Axogen, Inc. financial data

Symbol
AXGN on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
13631 Progress Blvd., Suite 400, Alachua, FL
State of incorporation
Minnesota
Fiscal year end
December 31
Former names
LECTEC CORP /MN/ (to 9/29/2011)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 325 % -19.9%
Quick Ratio 98.3 % +14.9%
Debt-to-equity 101 % +6.55%
Return On Equity -17.3 % +26.8%
Return On Assets -8.63 % +29%
Operating Margin -7.04 % +57.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.8M shares +1.97%
Common Stock, Shares, Outstanding 43.8M shares +1.97%
Entity Public Float 314M USD +41.9%
Common Stock, Value, Issued 438K USD +1.86%
Weighted Average Number of Shares Outstanding, Basic 43.7M shares +1.99%
Weighted Average Number of Shares Outstanding, Diluted 43.7M shares +1.99%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 173M USD +17.3%
Research and Development Expense 28.9M USD +5.85%
Selling and Marketing Expense 87.3M USD +11.9%
General and Administrative Expense 33.7M USD -12.1%
Costs and Expenses 150M USD +4.35%
Operating Income (Loss) -12.2M USD +50.6%
Nonoperating Income (Expense) -4.33M USD -450%
Net Income (Loss) Attributable to Parent -16.5M USD +29.5%
Earnings Per Share, Basic -0.37 USD/shares +35.1%
Earnings Per Share, Diluted -0.37 USD/shares +35.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.2M USD -17.4%
Accounts Receivable, after Allowance for Credit Loss, Current 25.2M USD +16.6%
Inventory, Net 28M USD +31.9%
Assets, Current 82.3M USD -4.54%
Operating Lease, Right-of-Use Asset 15M USD +7.12%
Intangible Assets, Net (Excluding Goodwill) 4.97M USD +22.7%
Assets 189M USD -1.41%
Accounts Payable, Current 11.8M USD +31.3%
Liabilities, Current 23.4M USD -2.16%
Operating Lease, Liability, Noncurrent 20.2M USD +0.49%
Other Liabilities, Noncurrent 94K USD
Liabilities 93.2M USD -1.32%
Retained Earnings (Accumulated Deficit) -290M USD -6.05%
Stockholders' Equity Attributable to Parent 95.7M USD -1.51%
Liabilities and Equity 189M USD -1.41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.3M USD -65.2%
Net Cash Provided by (Used in) Financing Activities 204K USD -67.8%
Net Cash Provided by (Used in) Investing Activities -3.25M USD -314%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 43.8M shares +1.97%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.3M USD -102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.2M USD -14.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD
Deferred Tax Assets, Valuation Allowance 61.1M USD +4.86%
Deferred Tax Assets, Gross 66.2M USD +5%
Depreciation 5.89M USD +102%
Payments to Acquire Property, Plant, and Equipment 924K USD -78.5%
Operating Lease, Liability, Current 1.75M USD +68.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 41.5M USD -2.95%
Amortization of Intangible Assets 267K USD -3.61%
Depreciation, Depletion and Amortization 1.52M USD +114%
Share-based Payment Arrangement, Expense 3.91M USD -27.5%
Interest Expense 5.15M USD +1699%